Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score–Matched Survival Outcome Comparisons.
Autor: | Oesterheld, Javier, Ferguson, William, Kraveka, Jacqueline M., Bergendahl, Genevieve, Clinch, Thomas, Lorenzi, Elizabeth, Berry, Don, Wada, Randal K., Isakoff, Michael S., Eslin, Don E., Brown, Valerie I., Roberts, William, Zage, Peter, Harrod, Virginia L., Mitchell, Deanna S., Hanson, Derek, Saulnier Sholler, Giselle L. |
---|---|
Zdroj: | Journal of Clinical Oncology; 1/1/2024, Vol. 42 Issue 1, p90-102, 14p |
Databáze: | Supplemental Index |
Externí odkaz: |